At long last, the risks to pregnant women of taking Sodium Valproate, an anti-convulsant drug prescribed for epilepsy, are receiving mainstream attention.
The drug can lead to a baby developing Sodium Valproate Syndrome, which can result in very distinct physical characteristics and developmental delay.
David Gazzard is the leading Sodium Valproate solicitor. He specialises in claims resulting from wrongly prescribed Sodium Valproate. David said “I’m delighted that at long last the danger posed by Sodium Valproate to pregnant women in their first trimester is receiving extensive news coverage.”
The BBC article highlights the fact that over many years, little effort has been made to draw the huge risks posed by Sodium Valproate to the attention of epileptic women. “Babies exposed to the drug in the womb have a 40% risk of developing autism, low IQ and learning disabilities”, with a 10% chance of developing physical abnormalities.